9 Meters Biopharma (9 Meters Biopharma) EV-to-EBIT : 0.04 (As of Apr. 26, 2024)

9 Meters Biopharma EV-to-EBIT Chart

9 Meters Biopharma Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
EV-to-EBIT		Get a 7-Day Free Trial					-3.32	-0.82	-2.40	-5.61	-0.57

9 Meters Biopharma Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EV-to-EBIT	Get a 7-Day Free Trial															-2.76	-0.84	-1.44	-0.57	-0.42

Competitive Comparison of 9 Meters Biopharma's EV-to-EBIT

For the Biotechnology subindustry, 9 Meters Biopharma's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

9 Meters Biopharma's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 9 Meters Biopharma's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where 9 Meters Biopharma's EV-to-EBIT falls into.

9 Meters Biopharma EV-to-EBIT Calculation

9 Meters Biopharma's EV-to-EBIT for today is calculated as:

9 Meters Biopharma's current Enterprise Value is $-1.77 Mil.
9 Meters Biopharma's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-42.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

9 Meters Biopharma  (OTCPK:NMTRQ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

9 Meters Biopharma's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

9 Meters Biopharma's Enterprise Value for the quarter that ended in Mar. 2023 was $18.16 Mil.
9 Meters Biopharma's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-42.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

9 Meters Biopharma EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of 9 Meters Biopharma's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

9 Meters Biopharma (9 Meters Biopharma) Business Description